Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE)

CUSIP: 83086J200

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.001
Shares outstanding
33,945,050
Total 13F shares
24,700,100
Share change
-477,593
Total reported value
$39,307,441
Put/Call ratio
25%
Price per share
$1.59
Number of holders
72
Value change
-$1,237,638
Number of buys
27
Number of sells
25

Security key

83086J200

Report period

Q1 2025

Institutions

72

Top holders

10

Top shareholders of SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SPHERA FUNDS MANAGEMENT LTD.
13F 13D/G
Company
4.8%
from 13D/G
1,564,628
$4,427,897 31 Dec 2024
5AM Venture Management, LLC
13F
Company
29%
9,913,168
$28,054,265 31 Dec 2024
13F
Versant Venture Management, LLC
13F
Company
5.9%
2,007,704
$5,681,802 31 Dec 2024
13F
BAKER BROS. ADVISORS LP
13F
Company
4.3%
1,450,638
$4,105,306 31 Dec 2024
13F
Schonfeld Strategic Advisors LLC
13F
Company
4.2%
1,422,741
$4,026,356 31 Dec 2024
13F
BlackRock, Inc.
13F
Company
3.6%
1,220,186
$3,453,127 31 Dec 2024
13F
Altium Capital Management LLC
13F
Company
3.4%
1,139,000
$3,223,370 31 Dec 2024
13F
VANGUARD GROUP INC
13F
Company
2.5%
860,827
$2,436,140 31 Dec 2024
13F
BRAIDWELL LP
13F
Company
2.4%
825,732
$2,336,822 31 Dec 2024
13F
Ensign Peak Advisors, Inc
13F
Company
2.3%
767,287
$2,171,422 31 Dec 2024
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.9%
650,758
$1,841,645 31 Dec 2024
13F
Alyeska Investment Group, L.P.
13F
Company
1.3%
456,163
$1,290,941 31 Dec 2024
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
1.3%
434,046
$1,228,350 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
405,694
$1,148,349 31 Dec 2024
13F
STATE STREET CORP
13F
Company
1.1%
374,504
$1,059,846 31 Dec 2024
13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
13F
Company
0.96%
326,241
$923,262 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.74%
250,014
$707,540 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.4%
135,712
$384,065 31 Dec 2024
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.33%
110,927
$282,864 31 Dec 2024
13F
AdvisorShares Investments LLC
13F
Company
0.26%
88,391
$250,147 31 Dec 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.21%
72,000
$203,760 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.21%
71,079
$201,154 31 Dec 2024
13F
BARCLAYS PLC
13F
Company
0.21%
69,620
$197,024 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.18%
62,363
$176,487 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
0.18%
61,026
$172,704 31 Dec 2024
13F
UBS Group AG
13F
Company
0.18%
59,576
$168,600 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
0.13%
44,908
$127,088 31 Dec 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.12%
40,835
$115,564 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.12%
39,257
$111,096 31 Dec 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.11%
36,057
$102,042 31 Dec 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.09%
31,637
$89,533 31 Dec 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.07%
23,389
$66,191 31 Dec 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.06%
21,653
$61,278 31 Dec 2024
13F
Zurcher Kantonalbank (Zurich Cantonalbank)
13F
Company
0.06%
21,560
$61,015 31 Dec 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
17,505
$49,532 31 Dec 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.05%
16,350
$46,271 31 Dec 2024
13F
CITIGROUP INC
13F
Company
0.04%
15,262
$43,192 31 Dec 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.04%
13,800
$39,054 31 Dec 2024
13F
Squarepoint Ops LLC
13F
Company
0.04%
13,546
$38,335 31 Dec 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.03%
11,200
$31,696 31 Dec 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.03%
11,199
$31,693 31 Dec 2024
13F
Virtu Financial LLC
13F
Company
0.03%
10,142
$29,000 31 Dec 2024
13F
Corebridge Financial, Inc.
13F
Company
0.03%
9,786
$27,694 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.03%
9,251
$26,181 31 Dec 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
3,473
$10,000 31 Dec 2024
13F
Police & Firemen's Retirement System of New Jersey
13F
Company
0.01%
3,462
$9,797 31 Dec 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
3,231
$9,144 31 Dec 2024
13F
FMR LLC
13F
Company
0.01%
2,151
$6,087 31 Dec 2024
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
1,687
$4,774 31 Dec 2024
13F
Financial Gravity Companies, Inc.
13F
Company
0%
1,600
$4,528 31 Dec 2024
13F

Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) as of Q1 2025

As of 31 Mar 2025, Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,700,100 shares. The largest 10 holders included 5AM Venture Management, LLC, Versant Venture Management, LLC, Schonfeld Strategic Advisors LLC, SPHERA FUNDS MANAGEMENT LTD., BAKER BROS. ADVISORS LP, BlackRock, Inc., VANGUARD GROUP INC, Altium Capital Management LLC, BRAIDWELL LP, and Ensign Peak Advisors, Inc. This page lists 72 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
70
Q1 2025 holders
72
Holder diff
2
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .